BR9709307A - Uso de interleucina-10 para produção de uma população de células supressoras - Google Patents

Uso de interleucina-10 para produção de uma população de células supressoras

Info

Publication number
BR9709307A
BR9709307A BR9709307A BR9709307A BR9709307A BR 9709307 A BR9709307 A BR 9709307A BR 9709307 A BR9709307 A BR 9709307A BR 9709307 A BR9709307 A BR 9709307A BR 9709307 A BR9709307 A BR 9709307A
Authority
BR
Brazil
Prior art keywords
interleukin
population
produce
suppressor cells
suppressor
Prior art date
Application number
BR9709307A
Other languages
English (en)
Inventor
Maria-Grazia Roncarolo
Rene De Waal Malefyt
Rosa Bacchetta
Herve M Groux
Jan E De Vries
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of BR9709307A publication Critical patent/BR9709307A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/515—CD3, T-cell receptor complex

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BR9709307A 1996-05-06 1997-05-02 Uso de interleucina-10 para produção de uma população de células supressoras BR9709307A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/643,810 US6277635B1 (en) 1992-03-04 1996-05-06 Use of interleukin-10 to produce a population of suppressor cells
PCT/US1997/007120 WO1997042324A1 (en) 1996-05-06 1997-05-02 Use of interleukin-10 to produce a population of suppressor cells

Publications (1)

Publication Number Publication Date
BR9709307A true BR9709307A (pt) 1999-08-10

Family

ID=24582315

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9709307A BR9709307A (pt) 1996-05-06 1997-05-02 Uso de interleucina-10 para produção de uma população de células supressoras

Country Status (16)

Country Link
US (1) US6277635B1 (pt)
EP (1) EP0906428A1 (pt)
JP (1) JP2000509604A (pt)
KR (1) KR20000010799A (pt)
AR (1) AR006942A1 (pt)
AU (1) AU2927597A (pt)
BR (1) BR9709307A (pt)
CA (1) CA2253803A1 (pt)
CZ (1) CZ347798A3 (pt)
IL (1) IL126658A0 (pt)
NO (1) NO985160L (pt)
NZ (1) NZ332413A (pt)
PL (1) PL329732A1 (pt)
SK (1) SK151898A3 (pt)
WO (1) WO1997042324A1 (pt)
ZA (1) ZA973815B (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6358506B1 (en) 1997-11-05 2002-03-19 University Of Southern California Use of cytokines and mitogens to inhibit pathological immune responses
WO1999030730A1 (en) * 1997-12-15 1999-06-24 Universite Laval Methods and compositions for improving the success of cell transplantation in a host
US6803036B1 (en) 1998-03-03 2004-10-12 University Of Southern California Use of cytokines, cells and mitogens to inhibit graft versus host disease
EP1061949B1 (en) 1998-03-03 2009-07-15 University of Southern California Cytokines and mitogens to inhibit graft-versus-host disease
WO2001016296A2 (en) * 1999-09-01 2001-03-08 University Of Southern California Use of cytokines, cells, and mitogens to inhibit graft versus host disease
GB9928193D0 (en) * 1999-11-29 2000-01-26 Univ Bristol Cell treatment method
WO2001077299A2 (en) 2000-04-11 2001-10-18 University Of Southern California A METHOD TO PREVENT GRAFT REJECTION USING TGF-β TO INDUCE T SUPPRESSOR CELLS
AU2001296962A1 (en) 2000-09-29 2002-04-08 Schering Corporation Pegylated interleukin-10
FR2824567B1 (fr) * 2001-05-11 2003-08-08 Inst Nat Sante Rech Med Procede d'obtention de lymphocytes tr1 regulateurs specifiques d'antigene
WO2003074685A2 (en) * 2002-03-07 2003-09-12 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Il-10 gene transfer to peripheral blood mononuclear cells
GB0214528D0 (en) * 2002-06-24 2002-08-07 Univ Aberdeen Materials and methods for induction of immune tolerance
DK1565183T3 (da) 2002-11-29 2008-12-01 Maria Grazia Roncarolo Rapamycin og IL-10 til behandling af autoimmune sygdomme
FR2852967B1 (fr) * 2003-03-26 2007-12-07 Txcell Procede d'obtention de cellules dendritiques et de cellules t
FR2856700B1 (fr) * 2003-06-24 2007-06-08 Txcell Procede d'identification de lymphocytes tr1 regulateurs par la presence et la surexpression de molecules specifiques et ses applications
EP2591786B1 (en) 2003-10-16 2017-04-12 Cancure Limited Immunomodulating compositions and uses therefor
CA2545841A1 (en) * 2003-11-12 2005-05-26 Txcell Use of lipopeptides for activating t lymphocytes through the skin
JP4863452B2 (ja) * 2006-03-30 2012-01-25 国立大学法人 千葉大学 ヒトＴｈ１／Ｔｈ２分化誘導系及びその用途
CA2652148C (en) 2006-05-12 2016-10-04 Fondazione Centro San Raffaele Del Monte Tabor Tolerogenic dendritic cells, method for their production and uses thereof
US20120058096A1 (en) 2009-03-03 2012-03-08 St. Jude Children's Research Hospital Compositions and methods for generating interleukin-35-induced regulatory t cells
US10143778B2 (en) * 2010-12-21 2018-12-04 Cormatrix Cardiovascular, Inc Cardiovascular prostheses
EP3882337A1 (en) 2012-06-18 2021-09-22 Ospedale San Raffaele S.r.l. Compositions and methods for diminishing an immune response
CA2782942C (en) * 2012-07-12 2019-08-27 Canadian Blood Services Method for inducing immune tolerance using polymer-modified antigenic leukocytes
US11007221B2 (en) 2013-07-12 2021-05-18 Canadian Blood Services Acellular pro-inflammatory compositions, process for making same and methods of using same
KR101868950B1 (ko) 2017-05-18 2018-06-19 연세대학교 산학협력단 Ｉｌ－１０을 발현하는 신경줄기세포를 포함하는 중추 신경계 질환 또는 손상의 치료용 약학적 조성물 및 이를 이용한 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4483920A (en) 1982-05-17 1984-11-20 Hahnemann University Immobilization of message RNA directly from cells onto filter material
US4559310A (en) 1983-05-20 1985-12-17 Dana Farber Cancer Institute Assay methods and systems utilizing mast cell clones
IL94878A (en) 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same

Also Published As

Publication number Publication date
IL126658A0 (en) 1999-08-17
EP0906428A1 (en) 1999-04-07
WO1997042324A1 (en) 1997-11-13
ZA973815B (en) 1997-11-03
NO985160L (no) 1999-01-06
SK151898A3 (en) 2000-04-10
AR006942A1 (es) 1999-09-29
AU2927597A (en) 1997-11-26
CZ347798A3 (cs) 1999-03-17
NZ332413A (en) 2000-10-27
PL329732A1 (en) 1999-04-12
CA2253803A1 (en) 1997-11-13
KR20000010799A (ko) 2000-02-25
NO985160D0 (no) 1998-11-05
US6277635B1 (en) 2001-08-21
JP2000509604A (ja) 2000-08-02

Similar Documents

Publication Publication Date Title
BR9709307A (pt) Uso de interleucina-10 para produção de uma população de células supressoras
MX164416B (es) Composicion para tocador
BR9702808A (pt) Utilização de pelo menos um retinóide apresentando uma atividade anti-ap-1
ID21556A (id) Pirazol yang bersifat parasitisida
BR9609154A (pt) Uso de linhagens de célula fetais neuro-derivadas para terapia de transplante
BR8901146A (pt) Pa para helice carenada
ES2013219A4 (es) Medio para conservar la madera y su aplicacion
PT897667E (pt) Composicao para melhorar o pao
BR9711165A (pt) M-todo para imortalizar c-lulas
DK0914133T3 (da) Anvendelse af hyaluronan (HA) til cellemobilisering
DE59710246D1 (de) Stabförmige Wägezelle
ID17419A (id) Komposisi dekafluoropentana
PT8746U (pt) Carcaca aperfeicoada para fogos de artificio
AR016434A1 (es) Procedimiento para preparar clorobenzoxazoles
DE59704755D1 (de) Verwendung von Dialkylethern
DE59804247D1 (de) Notfall-stütze zur stabilisierung einzelner gliedmassen oder körperpartien
KR960011685U (ko) 조명등 결합구조
BR9610187A (pt) Uso de ipriflavona para reduzir o número de células cd8+
LV12081A (lv) Augstas energoietilpibas akumulatori
KR970064057U (ko) 전원스위치의 스프링구조
KR960016557U (ko) 플로팅 스위치의 고정구조
KR970018150U (ko) 부동전의 개량구조
KR970049844U (ko) 압축기의 셀
KR960004255U (ko) 에어택커의 슛팅부 구조
KR960010231U (ko) 에어택커의 슛팅부 구조

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A , 6A , 7A , 8A , 9A E 10A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1876 DE 19/12/2006.

B15K Others concerning applications: alteration of classification

Ipc: A61K 39/00 (2006.01), A61K 38/20 (2006.0